Full-Time

Director – Medical

Pulmonary

Confirmed live in the last 24 hours

Deadline 6/1/25
Bristol Myers Squibb

Bristol Myers Squibb

10,001+ employees

Develops and delivers biopharmaceutical medicines

No salary listed

Senior, Expert

Company Historically Provides H1B Sponsorship

Lawrence Township, NJ, USA

Expected 20% travel within the continental US; hybrid work model with at least 50% onsite at your assigned facility.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Requirements
  • Advanced scientific degree (MD, PhD, PharmD, PA/NP)
  • Prior (5-10+ years) pharmaceutical industry experience in medical affairs is preferred
  • Highly organized and motivated individual with the ability to lead multiple projects and initiatives across diverse high performing matrix teams
  • Ability to work effectively within cross-functional teams
  • Excellent communication and presentation skills, both verbal and written
  • Understanding of pharmaceutical drug development including clinical development, regulatory, life cycle management of pharmaceutical products
  • Knowledge of thought leaders in the field
  • Clinical expertise and relevant experience in the disease area within the pharmaceutical industry, such as within Medical Affairs or Clinical Development
  • Ability to lead and develop people
  • Strong interpersonal and communication skills to navigate complex situations and gain alignment with diverse stakeholders
  • Demonstrated ability to execute and deliver results in a deadline-driven environment while managing multiple priorities
  • Strong understanding of business acumen including payer and market access challenges
  • Travel: Expected 20% travel within the continental US
Responsibilities
  • Provide input and advice to conduct the review of promotional materials for scientific/medical validity
  • Participate in internal and external meetings to remain current on changing regulations, relevant new medical/scientific information and commercial strategy
  • Establish clear and challenging goals that allow skilled and empowered professionals to accomplish business objectives
  • Support the execution of US medical plan that is both product and disease specific in alignment with US Commercialization (USC) and WW Medical (WWM)
  • Establish US Medical data generation strategies and collaborate with Medical Data Generation (MDG) to oversee the execution of the Investigator Sponsored Research (ISR) programs
  • Partner closely with colleagues in Discovery, Clinical Research, Regulatory, and Health Outcomes to ensure the science of the pipeline products and marketed medicines are understood and communicated properly
  • Engage with high impact external thought leaders to identify and translate key insights and to drive adoption of BMS medicines
  • Contribute to shape the competitive strategies around pricing and reimbursement
  • Demonstrate the ability to make effective decisions on selecting external organizations and researchers for research collaborations
  • Participate in mentoring, coaching and training of new and existing colleagues
Desired Qualifications
  • Prior (5-10+ years) pharmaceutical industry experience in medical affairs is preferred
  • The ideal candidate will have clinical expertise and some relevant experience in the disease area within the pharmaceutical industry, such as within Medical Affairs or Clinical Development

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, particularly in oncology, immunology, and cardiovascular health. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs that are affordable alternatives to their innovative medicines, ensuring they meet the same quality and safety standards. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, as well as its commitment to sustainability and corporate responsibility. The company's goal is to improve patient outcomes by providing effective and affordable healthcare solutions while adhering to Environmental, Social, and Governance (ESG) standards.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1887

Simplify Jobs

Simplify's Take

What believers are saying

  • BMS's $40B US investment signals strong commitment to growth despite cost-cutting.
  • AI partnership with Optellum enhances early lung cancer diagnosis and precision care.
  • Expansion in Gulf region under new leadership boosts market presence and opportunities.

What critics are saying

  • Layoffs and facility closures may disrupt production and market demand fulfillment.
  • New leadership appointments could shift company policy, impacting ongoing projects.
  • Acquisition of 2seventy bio may pose integration challenges affecting operational efficiency.

What makes Bristol Myers Squibb unique

  • BMS focuses on oncology, immunology, and cardiovascular diseases, setting it apart in biopharma.
  • The company invests heavily in R&D to develop innovative and generic medicines.
  • BMS emphasizes sustainability and ESG goals, enhancing its corporate responsibility image.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Company News

BioSpace
May 6th, 2025
BMS Pledges $40B Investment in US Despite Cost-Cutting Plans

This year alone BMS has laid off more than 800 employees, the bulk of which were just revealed this month, putting 516 jobs on the chopping block.

ROI-NJ
May 6th, 2025
Bristol Myers Squibb Names Gallman Executive Vp, General Counsel And Chief Policy Officer

Bristol Myers Squibb, the fourth-largest company in New Jersey by market cap, announced Tuesday the appointment of Cari Gallman as executive vice president, general counsel and chief policy officer, effective immediately. She succeeds Sandra (Sandy) Leung, who is retiring after a 33-year career at the company.Gallman has extensive experience in pharmaceutical law and compliance. She will lead the law department, which includes intellectual property, commercial and regulatory law, litigation, securities and corporate governance, transactions, corporate security and compliance and ethics, as well as global and U.S. policy and government affairs. Gallman has held leadership positions at Bristol Myers Squibb for 10 years, most recently serving as executive vice president, corporate affairs.“I am committed to continuing to build on the company’s culture of integrity and shape a dynamic policy environment that protects innovation and patients,” said Gallman in a statement.Gallman began her legal career in private practice representing pharmaceutical and medical device manufacturers in civil, regulatory, and government enforcement matters.She earned a bachelor’s degree in political theory from Princeton University, magna cum laude, and holds a juris doctor degree from Harvard Law School

Endpoints News
May 5th, 2025
Bristol Myers to lay off over 500 workers in New Jersey

Bristol Myers to lay off over 500 workers in New Jersey.

NJBIZ
May 5th, 2025
Bristol Myers Squibb plans 500+ layoffs in NJ

BMS recently announced plans to close a manufacturing facility in Illinois that handles viral vector production.

All Blog Things
May 3rd, 2025
BMS to lay off 516 employees at its Lawrence Township facility

BMS to lay off 516 employees at its Lawrence Township facility.